Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (51-60 of 254) with videos related to

Pageof 26
Sort By:
Pediatric Blood & Cancer|January 23, 2016
Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative DatabaseAmi V Desai, Alix E Seif, Yimei Li, et al.
Pediatric Blood & Cancer|August 15, 2015
Atypical Chronic Myeloid Leukemia in Two Pediatric PatientsJason L Freedman, Ami V Desai, L Charles Bailey, et al.
Cancer Medicine|June 14, 2019
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology GroupRajaram Nagarajan, Robert Gerbing, Todd Alonzo, et al.
Plos One|March 16, 2016
Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United StatesAmanda M DiNofia, Elizabeth Salazar, Alix E Seif, et al.
Pediatric Blood & Cancer|July 23, 2013
Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009Brian T Fisher, Sonia Singh, Yuan-Shung Huang, et al.
BMC Cancer|May 13, 2022
Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview studyLucky Ding, Julia E Szymczak, Erica Evans, et al.
Pediatric Blood & Cancer|December 27, 2018
Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemiaYimei Li, Joanna G Newton, Kelly D Getz, et al.
Pediatric Blood & Cancer|May 28, 2011
Germline genetic variation and treatment response on CCG-1891Dana M Sepe, Thomas McWilliams, Jinbo Chen, et al.
Cancers|February 15, 2022
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict SurvivalLauren Pommert, Todd M Cooper, Robert B Gerbing, et al.
Biomarker Research|July 26, 2016
Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case reportMargaret Lewen, Renee Gresh, Maria Queenan, et al.
Pageof 26

Showing results (51-60 of 254) with videos related to

Sort By:
Pageof 26
Pediatric Blood & Cancer|January 23, 2016
Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative DatabaseAmi V Desai, Alix E Seif, Yimei Li, et al.
Pediatric Blood & Cancer|August 15, 2015
Atypical Chronic Myeloid Leukemia in Two Pediatric PatientsJason L Freedman, Ami V Desai, L Charles Bailey, et al.
Cancer Medicine|June 14, 2019
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology GroupRajaram Nagarajan, Robert Gerbing, Todd Alonzo, et al.
Plos One|March 16, 2016
Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United StatesAmanda M DiNofia, Elizabeth Salazar, Alix E Seif, et al.
Pediatric Blood & Cancer|July 23, 2013
Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009Brian T Fisher, Sonia Singh, Yuan-Shung Huang, et al.
BMC Cancer|May 13, 2022
Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview studyLucky Ding, Julia E Szymczak, Erica Evans, et al.
Pediatric Blood & Cancer|December 27, 2018
Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemiaYimei Li, Joanna G Newton, Kelly D Getz, et al.
Pediatric Blood & Cancer|May 28, 2011
Germline genetic variation and treatment response on CCG-1891Dana M Sepe, Thomas McWilliams, Jinbo Chen, et al.
Cancers|February 15, 2022
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict SurvivalLauren Pommert, Todd M Cooper, Robert B Gerbing, et al.
Biomarker Research|July 26, 2016
Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case reportMargaret Lewen, Renee Gresh, Maria Queenan, et al.
Pageof 26